Treatment for Chlamydia
The first-line treatment for uncomplicated chlamydial infection is doxycycline 100 mg orally twice daily for 7 days, which should be prioritized over single-dose azithromycin based on the most recent evidence. 1
Recommended Treatment Regimens
First-Line Therapy
- Doxycycline 100 mg orally twice daily for 7 days is the preferred treatment 2, 1, 3
- This regimen achieves a 98% microbial cure rate and is equally effective in both men and women 2
- Doxycycline costs less than azithromycin and has no higher risk for adverse events 2
Alternative First-Line Option
- Azithromycin 1 g orally as a single dose remains an acceptable alternative 2, 3
- This achieves a 97% cure rate, essentially equivalent to doxycycline 2, 4
- Azithromycin should be specifically chosen when:
Second-Line Alternatives (When First-Line Options Unavailable)
- Erythromycin base 500 mg orally four times daily for 7 days 2
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 2
- Ofloxacin 300 mg orally twice daily for 7 days 2
- Levofloxacin 500 mg orally once daily for 7 days 2
Important caveat: Erythromycin is less efficacious than doxycycline or azithromycin due to frequent gastrointestinal side effects that reduce compliance 2. The fluoroquinolones (ofloxacin, levofloxacin) are more expensive and offer no dosing advantage 2.
Special Population: Pregnancy
- Erythromycin base or amoxicillin are the recommended treatments during pregnancy 5
- Doxycycline and fluoroquinolones are contraindicated in pregnancy 5
- Pregnant women require a test-of-cure 4 weeks after treatment completion 3
- Prenatal screening and treatment prevents neonatal chlamydial infection, including conjunctivitis and pneumonia 6
Critical Management Principles
Medication Dispensing
- Medications should be dispensed on-site with the first dose directly observed to maximize compliance 2
Sexual Abstinence Instructions
- Patients must abstain from sexual intercourse for 7 days after single-dose therapy or until completion of the entire 7-day regimen 2
- Patients must abstain until all sex partners are treated to minimize reinfection risk 2
Partner Treatment
- All sex partners must be treated to prevent reinfection of the index patient and transmission to others 2
- Coinfection with gonorrhea is common, so presumptive treatment for both infections is appropriate when gonorrhea is diagnosed 2
Follow-Up Testing Strategy
Test-of-Cure (NOT Routinely Recommended)
- Test-of-cure at 3-4 weeks is not recommended for non-pregnant patients treated with recommended regimens 2
- Exceptions requiring test-of-cure:
Critical pitfall: Testing <3 weeks after treatment can yield false-positive results from dead organisms or false-negative results from persistent low-level infection 2
Reinfection Screening (STRONGLY Recommended)
- All women with chlamydial infection should be retested approximately 3 months after treatment 2
- Women should also be retested at their next medical visit within 3-12 months, regardless of whether partners were treated 2
- This addresses the high prevalence of reinfection (not treatment failure), which confers elevated risk for pelvic inflammatory disease and complications 2
- Limited evidence exists for retesting men, though some specialists suggest it 2
Non-Pregnant Patients
- All non-pregnant patients should be tested for reinfection approximately 3 months after treatment or at the first visit within 12 months 3